Neuromuscular synaptic function in mice lacking major subsets of gangliosides

Neuroscience

Volumn 156, Issue 4, 2008, Pages 885-897

  Zitman, F M P ^a   Todorov, B ^a   Jacobs, B C ^b   Verschuuren, J J ^a   Furukawa, K ^c,c   Willison, H J ^d   Plomp, J J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

acetylcholine release; ganglioside; gene knockout; neuromuscular junction; synaptic transmission

Indexed keywords

ACETYLCHOLINE; CALCIUM; GANGLIOSIDE GD2; GANGLIOSIDE GD3; MUTANT PROTEIN; NEUROTRANSMITTER; SYNTHETASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EX VIVO STUDY; FEMALE; MALE; MOUSE; NERVE STIMULATION; NEUROLOGIC DISEASE; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SYNAPTIC TRANSMISSION; TEMPERATURE DEPENDENCE;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; GANGLIOSIDES; GANGLIOSIDOSES, GM2; MICE; MICE, KNOCKOUT; MUSCLE STRENGTH; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEUROMUSCULAR JUNCTION; RESPIRATION; SIALYLTRANSFERASES; SYNAPTIC POTENTIALS; SYNAPTIC TRANSMISSION; TEMPERATURE; TIME FACTORS;

EID: 53949117976     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.08.034     Document Type: Article

References (65)

1. Ando S., Tanaka Y., Waki H., Kon K., Iwamoto M., and Fukui F. Gangliosides and sialylcholesterol as modulators of synaptic functions. Ann N Y Acad Sci 845 (1998) 232-239
2. Ang C.W., Jacobs B.C., and Laman J.D. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol 25 (2004) 61-66
3. Buchwald B., Weishaupt A., Toyka K.V., and Dudel J. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett 201 (1995) 163-166
4. Bullens R.W., O'Hanlon G.M., Wagner E., Molenaar P.C., Furukawa K., Furukawa K., Plomp J.J., and Willison H.J. Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci 22 (2002) 6876-6884
5. Chamberlain L.H., Burgoyne R.D., and Gould G.W. SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc Natl Acad Sci U S A 98 (2001) 5619-5624
6. Chen Y.W., Pedersen J.W., Wandall H.H., Levery S.B., Pizette S., Clausen H., and Cohen S.M. Glycosphingolipids with extended sugar chain have specialized functions in development and behavior of Drosophila. Dev Biol 306 (2007) 736-749
7. Chiavegatto S., Sun J., Nelson R.J., and Schnaar R.L. A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp Neurol 166 (2000) 227-234
8. Desplats P.A., Denny C.A., Kass K.E., Gilmartin T., Head S.R., Sutcliffe J.G., Seyfried T.N., and Thomas E.A. Glycolipid and ganglioside metabolism imbalances in Huntington's disease. Neurobiol Dis 27 (2007) 265-277
9. Egorushkina N.V., Ratushnyak A.S., and Egorushkin I.V. The influence of exogenous gangliosides on the dynamics of the development of prolonged posttetanic potentiation. Neurosci Behav Physiol 23 (1993) 435-438
10. Fishman P.H. Role of membrane gangliosides in the binding and action of bacterial toxins. J Membr Biol 69 (1982) 85-97
11. Furuse H., Waki H., Kaneko K., Fujii S., Miura M., Sasaki H., Ito K.I., Kato H., and Ando S. Effect of the mono- and tetra-sialogangliosides, GM1 and GQ1b, on long-term potentiation in the CA1 hippocampal neurons of the guinea pig. Exp Brain Res 123 (1998) 307-314
12. Gong Y., Tagawa Y., Lunn M.P., Laroy W., Heffer-Lauc M., Li C.Y., Griffin J.W., Schnaar R.L., and Sheikh K.A. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain 125 (2002) 2491-2506
13. Green W.N., and Andersen O.S. Surface charges and ion channel function. Annu Rev Physiol 53 (1991) 341-359
14. Hakomori S. Structure, organization, and function of glycosphingolipids in membrane. Curr Opin Hematol 10 (2003) 16-24
15. Halstead S.K., O'Hanlon G.M., Humphreys P.D., Morrison D.B., Morgan B.P., Todd A.J., Plomp J.J., and Willison H.J. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127 (2004) 2109-2123
16. Halstead S.K., Zitman F.M., Humphreys P.D., Greenshields K., Verschuuren J.J., Jacobs B.C., Rother R.P., Plomp J.J., and Willison H.J. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131 (2008) 1197-1208
17. Hashiramoto A., Mizukami H., and Yamashita T. Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1. Oncogene 25 (2006) 3948-3955
18. Inoue M., Fujii Y., Furukawa K., Okada M., Okumura K., Hayakawa T., Furukawa K., and Sugiura Y. Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem 277 (2002) 29881-29888
19. Isaev D., Isaeva E., Shatskih T., Zhao Q., Smits N.C., Shworak N.W., Khazipov R., and Holmes G.L. Role of extracellular sialic acid in regulation of neuronal and network excitability in the rat hippocampus. J Neurosci 27 (2007) 11587-11594
20. Kaja S., van de Ven R.C., van Dijk J.G., Verschuuren J.J., Arahata K., Frants R.R., Ferrari M.D., van den Maagdenberg A.M., and Plomp J.J. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur J Neurosci 25 (2007) 2009-2020
21. Kappel T., Anken R.H., Hanke W., and Rahmann H. Gangliosides affect membrane-channel activities dependent on ambient temperature. Cell Mol Neurobiol 20 (2000) 579-590
22. Kawai H., Allende M.L., Wada R., Kono M., Sango K., Deng C., Miyakawa T., Crawley J.N., Werth N., Bierfreund U., Sandhoff K., and Proia R.L. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276 (2001) 6885-6888
23. Lang T., Bruns D., Wenzel D., Riedel D., Holroyd P., Thiele C., and Jahn R. SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J 20 (2001) 2202-2213
24. Ledeen R.W. Gangliosides of the neuron. Trends Neurosci 8 (1985) 169-174
25. Ledeen R.W., and Wu G. GM1 ganglioside: another nuclear lipid that modulates nuclear calcium. GM1 potentiates the nuclear sodium-calcium exchanger. Can J Physiol Pharmacol 84 (2006) 393-402
26. Liu Y., Wada R., Kawai H., Sango K., Deng C., Tai T., McDonald M.P., Araujo K., Crawley J.N., Bierfreund U., Sandhoff K., Suzuki K., and Proia R.L. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103 (1999) 497-505
27. Magleby K.L., and Stevens C.F. A quantitative description of end-plate currents. J Physiol 223 (1972) 173-197
28. Marconi S., Acler M., Lovato L., De Toni L., Tedeschi E., Anghileri E., Romito S., Cordioli C., and Bonetti B. Anti-GD2-like IgM autoreactivity in multiple sclerosis patients. Mult Scler 12 (2006) 302-308
29. McLachlan E.M., and Martin A.R. Non-linear summation of end-plate potentials in the frog and the mouse. J Physiol 311 (1980) 307-324
30. Meir A., Ginsburg S., Butkevich A., Kachalsky S.G., Kaiserman I., Ahdut R., Demirgoren S., and Rahamimoff R. Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol Rev 79 (1999) 1019-1088
31. Nakatani Y., Kawakami K., Nagaoka T., Utsunomiya I., Tanaka K., Yoshino H., Miyatake T., Hoshi K., and Taguchi K. Ca channel currents inhibited by serum from select patients with Guillain-Barre syndrome. Eur Neurol 57 (2007) 11-18
32. Ngamukote S., Yanagisawa M., Ariga T., Ando S., and Yu R.K. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J Neurochem 103 (2007) 2327-2341
33. O'Hanlon G.M., Plomp J.J., Chakrabarti M., Morrison I., Wagner E.R., Goodyear C.S., Yin X., Trapp B.D., Conner J., Molenaar P.C., Stewart S., Rowan E.G., and Willison H.J. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124 (2001) 893-906
34. Okada M., Itoh M.M., Haraguchi M., Okajima T., Inoue M., Oishi H., Matsuda Y., Iwamoto T., Kawano T., Fukumoto S., Miyazaki H., Furukawa K., Aizawa S., and Furukawa K. b-Series ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277 (2002) 1633-1636
35. Ortiz N., Rosa R., Gallardo E., Illa I., Tomas J., Aubry J., Sabater M., and Santafe M. IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release. J Neuroimmunol 119 (2001) 114-123
36. Plomp J.J., Molenaar P.C., O'Hanlon G.M., Jacobs B.C., Veitch J., Daha M.R., van Doorn P.A., van der Meche F.G., Vincent A., Morgan B.P., and Willison H.J. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol 45 (1999) 189-199
37. Proia R.L. Glycosphingolipid functions: insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci 358 (2003) 879-883
38. Rahmann H., Jonas U., Kappel T., and Hilderbrandt H. Differential involvement of gangliosides versus phospholipids in the process of temperature adaptation in vertebrates. A comparative phenomenological and physicochemical study. Ann N Y Acad Sci 845 (1998) 72-91
39. Ramirez O.A., Gomez R.A., and Carrer H.F. Gangliosides improve synaptic transmission in dentate gyrus of hippocampal rat slices. Brain Res 506 (1990) 291-293
40. Roth J., Kempf A., Reuter G., Schauer R., and Gehring W.J. Occurrence of sialic acids in Drosophila melanogaster. Science 256 (1992) 673-675
41. Salaun C., James D.J., and Chamberlain L.H. Lipid rafts and the regulation of exocytosis. Traffic 5 (2004) 255-264
42. Santafe M.M., Sabate M.M., Garcia N., Ortiz N., Lanuza M.A., and Tomas J. Changes in the neuromuscular synapse induced by an antibody against gangliosides. Ann Neurol 57 (2005) 396-407
43. Sheikh K.A., Sun J., Liu Y., Kawai H., Crawford T.O., Proia R.L., Griffin J.W., and Schnaar R.L. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A 96 (1999) 7532-7537
44. Simpson M.A., Cross H., Proukakis C., Priestman D.A., Neville D.C., Reinkensmeier G., Wang H., Wiznitzer M., Gurtz K., Verganelaki A., Pryde A., Patton M.A., Dwek R.A., Butters T.D., Platt F.M., and Crosby A.H. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36 (2004) 1225-1229
45. Sohn H., Kim Y.S., Kim H.T., Kim C.H., Cho E.W., Kang H.Y., Kim N.S., Kim C.H., Ryu S.E., Lee J.H., and Ko J.H. Ganglioside GM3 is involved in neuronal cell death. FASEB J 20 (2006) 1248-1250
46. Sonnino S., Mauri L., Chigorno V., and Prinetti A. Gangliosides as components of lipid membrane domains. Glycobiology 17 (2007) 1R-13R
47. Stevens C.F., and Tsujimoto T. Estimates for the pool size of releasable quanta at a single central synapse and for the time required to refill the pool. Proc Natl Acad Sci U S A 92 (1995) 846-849
48. Sugiura Y., Furukawa K., Tajima O., Mii S., Honda T., and Furukawa K. Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides. Neuroscience 135 (2005) 1167-1178
49. Susuki K., Baba H., Tohyama K., Kanai K., Kuwabara S., Hirata K., Furukawa K., Furukawa K., Rasband M.N., and Yuki N. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55 (2007) 746-757
50. Svennerholm L. Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog Brain Res 101 (1994) XI-XIV
51. Takamiya K., Yamamoto A., Furukawa K., Yamashiro S., Shin M., Okada M., Fukumoto S., Haraguchi M., Takeda N., Fujimura K., Sakae M., Kishikawa M., Shiku H., Furukawa K., and Aizawa S. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A 93 (1996) 10662-10667
52. 2+ influx and acetylcholine release in brain synaptosomes. Neuroreport 8 (1997) 2203-2207
53. Taverna E., Saba E., Rowe J., Francolini M., Clementi F., and Rosa P. Role of lipid microdomains in P/Q-type calcium channel (Cav2.1) clustering and function in presynaptic membranes. J Biol Chem 279 (2004) 5127-5134
54. Tettamanti G., Bonali F., Marchesini S., and Zambotti V. A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296 (1973) 160-170
55. Varoqueaux F., Sons M.S., Plomp J.J., and Brose N. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. Mol Cell Biol 25 (2005) 5973-5984
56. 2+-ATPase. FEBS Lett 457 (1999) 144-148
57. Wieraszko A., and Seifert W. The role of monosialoganglioside GM1 in the synaptic plasticity: in vitro study on rat hippocampal slices. Brain Res 345 (1985) 159-164
58. Willison H.J., and Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (2002) 2591-2625
59. Wood S.J., and Slater C.R. Safety factor at the neuromuscular junction. Prog Neurobiol 64 (2001) 393-429
60. Wu G., Lu Z.H., Obukhov A.G., Nowycky M.C., and Ledeen R.W. Induction of calcium influx through TRPC5 channels by cross-linking of GM1 ganglioside associated with alpha5beta1 integrin initiates neurite outgrowth. J Neurosci 27 (2007) 7447-7458
61. Wu G., Lu Z.H., Wang J., Wang Y., Xie X., Meyenhofer M.F., and Ledeen R.W. Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. J Neurosci 25 (2005) 11014-11022
62. Wu G., Lu Z.H., Xie X., and Ledeen R.W. Susceptibility of cerebellar granule neurons from GM2/GD2 synthase-null mice to apoptosis induced by glutamate excitotoxicity and elevated KCl: rescue by GM1 and LIGA20. Glycoconj J 21 (2004) 305-313
63. Wu G.S., Vaswani K.K., Lu Z.H., and Ledeen R.W. Gangliosides stimulate calcium flux in neuro-2A cells and require exogenous calcium for neuritogenesis. J Neurochem 55 (1990) 484-491
64. Yamashita T., Wu Y.P., Sandhoff R., Werth N., Mizukami H., Ellis J.M., Dupree J.L., Geyer R., Sandhoff K., and Proia R.L. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci U S A 102 (2005) 2725-2730
65. Yates A.J., and Rampersaud A. Sphingolipids as receptor modulators. An overview. Ann N Y Acad Sci 845 (1998) 57-71